KRAS is one of the oncogenes most frequently altered in cancer, mutated in approximately one-third of lung adenocarcinomas.
Researchers have discovered a new way in which RAS genes, which are commonly mutated in cancer, may drive tumor growth beyond their well-known role in signaling at the cell surface. Mutant RAS, they ...
When it comes to cancer, tumor suppressor genes are usually thought of as the "good guys." These genes make proteins that ...
National Institutes of Health (NIH) scientists and collaborators say they have discovered a new way in which RAS genes, commonly mutated in cancer, may drive tumor growth beyond their well-known role ...
Data showcase advances across oncology pipeline including pan-mutant BRAF, CBL-B and AURKA programsPresentations reinforce potential of degraders ...
Schematic illustrating the effects of p53C and M237I in driving the conversion of p63C and p73C droplets into amyloid aggregates at physiologically relevant temperatures. Heparin prevents the ...
Huntington’s disease (HD) is a devastating brain disorder that slowly robs people of movement, memory and personality. It is caused by a toxic, mutant Huntingtin (mHTT) protein that builds in brain ...
Researchers from Elpiscience Biopharmaceuticals Inc. discussed the discovery and preclinical characterization of a novel NKG2A antibody-IL-2 mutant fusion protein – ES-015.129 – being developed as ...
GNAO1 encephalopathy therapy: from thousands of candidates to one. Pediatric GNAO1 encephalopathies are rare but severe brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results